New publication: Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome

We review the possible role of androgens in the pathophysiology of skeletal muscle abnormalities in PCOS, and identify knowledge gaps, areas for future research and potential therapeutic implications. Despite increasing interest in the area of skeletal muscle dysfunction in women with PCOS, significant challenges and unanswered questions remain, and going forward, novel innovative approaches will be required to dissect the underlying mechanisms.
Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome
Recent News posts
NEW REVIEW: 11-Oxy Androgens in Human Health
A new review co-authored by Clinical Lead, Prof Michael O'Reilly alongside prominent biochemist, Prof Karl-Heinz Storbeck (Stellenbosch University,…
Research seminar series April 2023
Team member Stephanie Agabana MSc, will be presenting her research into androgens in endocrine resistant breast cancers at…
Development of a novel 3D bioprinting model to explore skeletal muscle energy metabolism in women with PCOS
Funding has been awarded to Dr McIlroy and Prof O'Reilly to develop a 3D bioprinting model to explore…
GRANTS UPDATE
RCSI Translational Seed Funding (October 2022) Project: ‘Utilising a 3D bioprinting model to dissect the impact of androgen excess…